Sponsor or institution

Clinical trials and research at Verrica Pharmaceuticals Inc.

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Cantharidin and occlusion in verruca epithelium: testing a topical treatment for common warts

  This Phase 3 study tests VP-102/TO-208 (cantharidin) vs. a vehicle to see if it clears common warts in people 2 years and older who have a normal immune system.

  Recruiting at 14 sites Phase 3 Verrica Pharmaceuticals Inc. · San Diego, California and 19 other locations · NCT07637734

• Long-term follow-up of cantharidin (YCANTH/VP-102/TO-208) treatment for common warts

  This follow-up will try applying cantharidin (YCANTH/VP-102/TO-208) every ~21 days for up to four applications to see if it safely clears remaining common warts in people who completed earlier COVE studies.

  Recruiting at 12 sites Phase 3 Verrica Pharmaceuticals Inc. · Saint Augustine, Florida and 11 other locations · NCT07457918

Quick answers

How many clinical trials run by Verrica Pharmaceuticals Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Japan (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →